Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1392151rdf:typepubmed:Citationlld:pubmed
pubmed-article:1392151lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:1392151lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:1392151lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:1392151lifeskim:mentionsumls-concept:C0521116lld:lifeskim
pubmed-article:1392151pubmed:issue2lld:pubmed
pubmed-article:1392151pubmed:dateCreated1992-11-12lld:pubmed
pubmed-article:1392151pubmed:abstractTextGM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) activates neutrophil, eosinophil, granular, and macrophage precursors through binding to specific receptors. GM-CSF receptor is a member of the "cytokine receptor superfamily", which displays a particular transmembrane structure. It is expressed in small amounts on normal mature blood or medullary cells, with a high affinity. On acute myeloid leukemia blasts (18 patients), our results agree with the review of the literature: GM-CSF receptors are in small amounts, of two types (high and low affinity), with no relation to the FAB classification of leukemias.lld:pubmed
pubmed-article:1392151pubmed:languagefrelld:pubmed
pubmed-article:1392151pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1392151pubmed:citationSubsetIMlld:pubmed
pubmed-article:1392151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1392151pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1392151pubmed:statusMEDLINElld:pubmed
pubmed-article:1392151pubmed:issn0007-4551lld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:NajeanYYlld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:ChomienneCClld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:DombretHHlld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:ToubertM EMElld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:KrawiceIIlld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:SchlageterM...lld:pubmed
pubmed-article:1392151pubmed:authorpubmed-author:de GentileAAlld:pubmed
pubmed-article:1392151pubmed:issnTypePrintlld:pubmed
pubmed-article:1392151pubmed:volume79lld:pubmed
pubmed-article:1392151pubmed:ownerNLMlld:pubmed
pubmed-article:1392151pubmed:authorsCompleteYlld:pubmed
pubmed-article:1392151pubmed:pagination123-31lld:pubmed
pubmed-article:1392151pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:1392151pubmed:meshHeadingpubmed-meshheading:1392151-...lld:pubmed
pubmed-article:1392151pubmed:meshHeadingpubmed-meshheading:1392151-...lld:pubmed
pubmed-article:1392151pubmed:meshHeadingpubmed-meshheading:1392151-...lld:pubmed
pubmed-article:1392151pubmed:meshHeadingpubmed-meshheading:1392151-...lld:pubmed
pubmed-article:1392151pubmed:year1992lld:pubmed
pubmed-article:1392151pubmed:articleTitle[Current data on GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) in acute myeloid leukemia].lld:pubmed
pubmed-article:1392151pubmed:affiliationService de médecine nucléaire, hôpital Saint-Louis, Paris, France.lld:pubmed
pubmed-article:1392151pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1392151pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1392151pubmed:publicationTypeReviewlld:pubmed
pubmed-article:1392151pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed